Looking for trustworthy answers? Westonci.ca is the ultimate Q&A platform where experts share their knowledge on various topics. Explore thousands of questions and answers from knowledgeable experts in various fields on our Q&A platform. Connect with a community of professionals ready to provide precise solutions to your questions quickly and accurately.

An older female adalt client with myasthenia gravis is concerned about the cost of medications under her Medicare prescription drug plan. She questions the necessity of neostigmine (Prostigmin) and pyrldastigmine bromide (Mestinen). What information is important to provide this client to promote: drug compliance following discharge?